Weimin Liu Selected Research

Weimin Liu Research Topics

Disease

45	Neoplasms (Cancer) 10/2022 - 01/2002
10	Infections 10/2022 - 06/2009
6	Melanoma (Melanoma, Malignant) 10/2022 - 02/2010
6	Atherosclerosis 01/2018 - 03/2004
6	Inflammation (Inflammations) 07/2015 - 08/2003
4	Rheumatoid Arthritis 10/2018 - 05/2002
4	Asthma (Bronchial Asthma) 01/2018 - 04/2008
4	Malaria 01/2018 - 01/2014
4	Stroke (Strokes) 10/2008 - 01/2003
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 10/2021
3	Hypertension (High Blood Pressure) 12/2019 - 03/2004
3	Ovarian Neoplasms (Ovarian Cancer) 03/2018 - 02/2017
3	Arthritis (Polyarthritis) 11/2014 - 05/2002
3	Fibrosarcoma 01/2007 - 05/2002
2	Breast Neoplasms (Breast Cancer) 09/2022 - 12/2020
2	COVID-19 01/2022 - 01/2021
2	Glioblastoma (Glioblastoma Multiforme) 12/2021 - 06/2020
2	Pneumonia (Pneumonitis) 01/2021 - 01/2002
2	Wounds and Injuries (Trauma) 07/2020 - 02/2013
2	Diabetes Mellitus 01/2020 - 12/2019
2	Hypoxia (Hypoxemia) 03/2018 - 01/2005
2	Cough 01/2017 - 01/2014
2	Thrombocytopenia (Thrombopenia) 01/2017 - 12/2014
2	Necrosis 04/2015 - 04/2007
2	Fibrosis (Cirrhosis) 02/2015 - 02/2006
2	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2013 - 12/2003
2	Atherosclerotic Plaque (Atheroma) 12/2011 - 03/2010
2	Vascular System Injuries 07/2009 - 01/2003
2	Autoimmune Diseases (Autoimmune Disease) 07/2004 - 06/2004
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2003 - 10/2003
1	Hepatitis 10/2022
1	Vitiligo 10/2022
1	Melanosis (Freckles) 10/2022
1	Phototoxic Dermatitis (Phototoxicity) 08/2022
1	Osteoarthritis 01/2022
1	Primary Ovarian Insufficiency 01/2022

Drug/Important Bio-Agent (IBA)

12	CytokinesIBA 01/2021 - 01/2002
10	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2021 - 08/2014
8	Messenger RNA (mRNA)IBA 01/2022 - 05/2002
6	hypocrellin AIBA 12/2021 - 12/2018
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2003
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018 - 05/2002
5	Photosensitizing Agents (Photosensitizers)IBA 08/2022 - 06/2017
5	Cisplatin (Platino)FDA LinkGeneric 03/2018 - 06/2015
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 01/2003
4	Singlet OxygenIBA 08/2021 - 03/2018
3	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2002
3	AntigensIBA 10/2022 - 01/2014
3	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2014
3	CarbonIBA 06/2019 - 03/2018
3	Interleukin-8 (Interleukin 8)IBA 05/2017 - 10/2011
3	InterleukinsIBA 04/2015 - 01/2007
3	Pharmaceutical PreparationsIBA 11/2014 - 07/2012
3	InflammasomesIBA 02/2013 - 02/2010
3	AntioxidantsIBA 10/2011 - 01/2003
3	Interleukin-1beta (Interleukin 1 beta)IBA 02/2010 - 01/2003
3	Fibroblast Growth Factor 1 (FGF-1)IBA 01/2007 - 05/2002
3	ChemokinesIBA 01/2007 - 01/2003
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2003 - 05/2002
2	MicroRNAs (MicroRNA)IBA 10/2022 - 03/2016
2	Coloring Agents (Dyes)IBA 01/2022 - 10/2012
2	Therapeutic UsesIBA 05/2021 - 06/2015
2	Glycoproteins (Glycoprotein)IBA 01/2021 - 10/2007
2	AntibodiesIBA 01/2021 - 05/2011
2	Amino Acids FDA Link 01/2021 - 01/2011
2	RNA (Ribonucleic Acid)IBA 08/2020 - 06/2015
2	Temozolomide (Temodar)FDA LinkGeneric 06/2020 - 10/2012
2	Oxygen (Dioxygen)IBA 01/2019 - 03/2018
2	Ethanol (Ethyl Alcohol)IBA 01/2018 - 11/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 06/2014
2	Interleukin-6 (Interleukin 6)IBA 05/2017 - 01/2002
2	CalciumIBA 04/2016 - 04/2007
2	PolyphenolsIBA 02/2015 - 10/2011
2	LubricantsIBA 11/2014 - 05/2014
2	Nogo Receptor 1IBA 07/2014 - 02/2013
2	Phosphotransferases (Kinase)IBA 04/2014 - 02/2013
2	Mitochondrial DNA (mtDNA)IBA 04/2013 - 07/2012
2	Small Interfering RNA (siRNA)IBA 02/2013 - 02/2010
2	Hemagglutinins (Hemagglutinin)IBA 05/2011 - 10/2007
2	Biological ProductsIBA 10/2008 - 01/2007
2	Peroxynitrous Acid (Peroxynitrite)IBA 03/2004 - 10/2003
2	Celecoxib (Celebrex)FDA Link 08/2003 - 08/2003
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 10/2022
1	Melanins (Melanin)IBA 10/2022
1	iron phthalocyanineIBA 01/2022
1	XanthenesIBA 01/2022
1	gadolinium ethoxybenzyl DTPA FDA Link 01/2022
1	Contrast MediaIBA 01/2022
1	EnzymesIBA 01/2022
1	VaccinesIBA 01/2022
1	CateninsIBA 01/2022

Therapy/Procedure

20	Therapeutics 01/2022 - 01/2002
12	Photochemotherapy (Photodynamic Therapy) 08/2022 - 05/2017
7	Photothermal Therapy 01/2022 - 06/2017
5	Drug Therapy (Chemotherapy) 12/2020 - 03/2011
3	Radiotherapy 01/2019 - 01/2002
3	Injections 05/2014 - 01/2003
2	Adjuvant Chemotherapy 09/2022 - 12/2020
2	Precision Medicine 01/2022 - 12/2018
2	Phototherapy (Light Therapy) 06/2019 - 06/2017